In the meantime, consider alternatives such as GLP-1 agonists like Wegovy, already on the market and endorsed by Klinic, with prior authorization support and insurance coverage options
We use the patented First Line Therapy (FLT) weight loss program and the HCG Diet protocol
Management: Small, bland meals
48 In patients with MASH-related cirrhosis and severe portal hypertension, emricasan could not improve either HVPG or clinical outcomes (NCT02960204)
placebo, N=113), the adverse reactions reported regardless of investigator assessment of causality in 5% of patients treated with sitagliptin and more commonly than in patients treated with placebo were: hypoglycemia (Table 3) and headache (6.9%, 2.7%)
Second, resting heart rate increased modestly during treatment (average 2-4 beats per minute above baseline)